skip to:
page content
|
links on this page
|
site navigation
|
footer (site information)
Antibody Technologies, Inc.
CDC
|
BioIT
|
Nature
Corporate Overview
Research
Careers
Contact Us
Corporate Overview
|
Mission Statement
|
Business Strategy
|
History
subglobal2 link
|
subglobal2 link
|
subglobal2 link
|
subglobal2 link
subglobal3 link
|
subglobal3 link
|
subglobal3 link
|
subglobal3 link
subglobal4 link
|
subglobal4 link
|
subglobal4 link
|
subglobal4 link
Home
Contact Us
Moving towards new horizons in the 21st century.
Corporate Overview
Antibody Technologies, Inc. is a biotechnology company that specializes in bringing antibody-based technologies to the market. We develop, manufacture and sell diagnostic kits and reagents for commercial and consumer use.
Headlines
Monoclonal Antibody Therapies: Evolving into a $30 billion market
Research and Markets: Market for Monoclonal Antibody Therapeutics Has Been Growing at an Impressive Compound Average Annual Growth Rate of 42% Over Previous Five Years.
©2005 Waltair Technical Services, Inc.
